Nontypeable Pneumococci Can Be Divided into Multiple
            <i>cps</i>
            Types, Including One Type Expressing the Novel Gene
            <i>pspK</i>

Park, Inho; Kim, Kyung-Hyo; Andrade, Ana Lúcia; Briles, David E.; McDaniel, Larry S.; Nahm, Moon H.

doi:10.1128/mbio.00035-12

Cited by 101 publications

(171 citation statements)

References 55 publications

Supporting

Mentioning

170

Contrasting

Order By: Relevance

“…Genetic studies of cps loci from NT isolates revealed two broad NT groups (110,111). Group I NT isolates retain the characteristic genetic elements of the cps locus (112,113), while cps loci of group II NT isolates do not encode PS synthesis machinery but have genes for distinct proteins such as PspK (also identified as NspA) (100,111) and homologs of the putative peptide permease AliB (110,111). These proteins may facilitate epithelial adhesion and colonization, as almost all NT isolates from the NP belong to group II.…”

Section: Nontypeable Pneumococcimentioning

confidence: 99%

Pneumococcal Capsules and Their Types: Past, Present, and Future

et al. 2015

Self Cite

View full text Add to dashboard Cite

SUMMARY Streptococcus pneumoniae (the pneumococcus) is an important human pathogen. Its virulence is largely due to its polysaccharide capsule, which shields it from the host immune system, and because of this, the capsule has been extensively studied. Studies of the capsule led to the identification of DNA as the genetic material, identification of many different capsular serotypes, and identification of the serotype-specific nature of protection by adaptive immunity. Recent studies have led to the determination of capsular polysaccharide structures for many serotypes using advanced analytical technologies, complete elucidation of genetic basis for the capsular types, and the development of highly effective pneumococcal conjugate vaccines. Conjugate vaccine use has altered the serotype distribution by either serotype replacement or switching, and this has increased the need to serotype pneumococci. Due to great advances in molecular technologies and our understanding of the pneumococcal genome, molecular approaches have become powerful tools to predict pneumococcal serotypes. In addition, more-precise and -efficient serotyping methods that directly detect polysaccharide structures are emerging. These improvements in our capabilities will greatly enhance future investigations of pneumococcal epidemiology and diseases and the biology of colonization and innate immunity to pneumococcal capsules.

show abstract

Section: Nontypeable Pneumococcimentioning

confidence: 99%

Pneumococcal Capsules and Their Types: Past, Present, and Future

et al. 2015

Self Cite

View full text Add to dashboard Cite

show abstract

“…Firstly, there has been an increase in NESp prevalence as it was observed that strains increased from 1.5% in 2001 to 5.1% in 2006. 32 However, at any point in time NESp frequency can be between 3–19% worldwide. 33 This is important, as current conjugate vaccines do not protect against NESp.…”

Section: Discussionmentioning

confidence: 99%

“…These strains have been associated with causing conjunctivitis, IPD, otitis media, and carriage. 32 Strains can be divided into two classes. Class I types contain the cps locus which normally codes for the CPS; however, mutations or disruptions prevent the bacteria from making a capsule.…”

Section: Characteristics Of the Bacteriummentioning

confidence: 99%

“…Class II types, on the other hand, completely lack the cps locus and genes required to produce a capsule, and instead have novel genes and virulence factors. 32-34 Typically, the CPS is the primary virulence factor and without it strains cannot readily colonize or cause disease. However, NESp have been shown to colonize the nasopharynx.…”

Section: Characteristics Of the Bacteriummentioning

confidence: 99%

See 1 more Smart Citation

Current status and future directions of invasive pneumococcal diseases and prophylactic approaches to control them

Wantuch

Avci

2018

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Streptococcus pneumoniae is a major human bacterial pathogen responsible for millions of deaths each year and significantly more illnesses worldwide. With over 90 different serotypes, providing effective vaccine programs has been a continuing challenge. Since 1983, the world has been introduced to four different pneumococcal vaccines (PPSV23, PCV7, PCV10, and PCV13) each with their own complications and successes. Since vaccination programs began, a decrease in the overall rate of pneumococcal pneumonia and associated diseases has been observed, notably in higher risk populations. However, with a decrease in incidence of vaccine type pneumococcal serotypes, increases in non-vaccine serotypes of the bacteria have been observed along with serotype switching. Additionally, a rise in antibiotic resistant strains of S. pneumoniae is noted. Here we discuss both the positive and negative clinical manifestations of pneumonia vaccine programs and discuss the challenges in pneumococcal vaccine design.

show abstract

“…Group I NT strains possess a cps locus very similar to that of encapsulated strains. Group II NT strains lack the vast majority of the cps locus and instead harbor other genes, such as pspK (encoding an LPXTG-anchored protein potentially involved in epithelial adhesion and invasion), nspA [encoding a novel surface protein which may interact with the human poly(Ig) receptor], and genes with significant sequence similarity to aliB, which encodes a pep-tide-binding molecule associated with an ABC transporter (19)(20)(21)(22)(23). While it is clear that the replacement of the entire cps locus results in an acapsular strain, the molecular mechanism(s) responsible for reduced/loss of capsule in conjunctival clinical isolates with a seemingly intact cps locus is incompletely understood.…”

mentioning

confidence: 99%

Mutations in Pneumococcal cpsE Generated via In Vitro Serial Passaging Reveal a Potential Mechanism of Reduced Encapsulation Utilized by a Conjunctival Isolate

et al. 2015

View full text Add to dashboard Cite

The polysaccharide capsule of Streptococcus pneumoniae is required for nasopharyngeal colonization and for invasive disease in the lungs, blood, and meninges. In contrast, the vast majority of conjunctival isolates are acapsular. The first serotype-specific gene in the capsule operon, cpsE, encodes the initiating glycosyltransferase and is one of the few serotype-specific genes that can tolerate null mutations. This report characterizes a spontaneously arising TIGR4 mutant exhibiting a reduced capsule, caused by a 6-nucleotide duplication in cpsE which results in duplication of Ala and Ile at positions 45 and 46. This strain (AI45dup) possessed more exposed phosphorylcholine and was hypersusceptible to C3 complement deposition compared to the wild type. Accordingly, the mutant was significantly better at forming abiotic biofilms and binding epithelial cells in vitro but was avirulent in a sepsis model. In vitro serial passaging of the wild-type strain failed to reproduce the AI45dup mutation but instead led to a variety of mutants with reduced capsule harboring single nucleotide polymorphisms (SNPs) in cpsE. A single passage in the sepsis model after high-dose inoculation readily yielded revertants of AI45dup with restored wild-type capsule level, but the majority of SNP alleles of cpsE could not revert, suppress, or bypass. Analysis of cpsE in conjunctival isolates revealed a strain with a single missense mutation at amino acid position 377, which was responsible for reduced encapsulation. This study supports the hypothesis that spontaneous, nonreverting mutations in cpsE serve as a form of adaptive mutation by providing a selective advantage to S. pneumoniae in niches where expression of capsule is detrimental. IMPORTANCEWhile the capsule of Streptococcus pneumoniae is required for colonization and invasive disease, most conjunctival isolates are acapsular by virtue of deletion of the entire capsular operon. We show that spontaneous acapsular mutants isolated in vitro harbor mostly nonrevertible single nucleotide polymorphism (SNP) null mutations in cpsE, encoding the initiating glycosyltransferase. From a small collection of acapsular conjunctival isolates, we identified one strain with a complete capsular operon but containing a SNP in cpsE that we show is responsible for the acapsular phenotype. We propose that acapsular conjunctival isolates may arise initially from such nonreverting SNP null mutations in cpsE, which can be followed later by deletion of portions or all of the cps operon. Streptococcus pneumoniae (the pneumococcus) is a Gram-positive bacterium that is frequently found as a commensal organism of the human nasopharynx. However, depending on the site of dissemination, it can also cause various invasive diseases, including pneumonia, otitis media, sepsis, and meningitis (1-4). One critical pneumococcal virulence factor is the capsular polysaccharide (capsule), of which over 90 different serotypes have been characterized. The capsule has many important immune evasion functions, including...

show abstract

Nontypeable Pneumococci Can Be Divided into Multiple cps Types, Including One Type Expressing the Novel Gene pspK

Cited by 101 publications

References 55 publications

Pneumococcal Capsules and Their Types: Past, Present, and Future

Pneumococcal Capsules and Their Types: Past, Present, and Future

Current status and future directions of invasive pneumococcal diseases and prophylactic approaches to control them

Mutations in Pneumococcal cpsE Generated via In Vitro Serial Passaging Reveal a Potential Mechanism of Reduced Encapsulation Utilized by a Conjunctival Isolate

Contact Info

Product

Resources

About